AIZ vs TBPH · P/E 15, rev $3.45B vs P/E 7.5, rev $38.4M
Assurant Inc (AIZ) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the AIZ and TBPH stock pages for the full models.
Not investment advice.